Nipocalimab, an FcRn blocker, receives FDA Fast Track status for SLE treatment after demonstrating significant improvements in disease activity.

InvestigateTV+ shares a young mother’s struggle with the debilitating effects of lupus. Plus, we take an in-depth look at what could become a breakthrough treatment.

March is National Kidney Month, a time to shine a light on the thousands of individuals whose lives are deeply affected by ...

It's more important than ever before for your elected officials to hear from you - don't miss your chance to turn Capitol Hill purple at the 2026 National Lupus Advocacy Summit this April!

Fast Track designation reflects the unmet need in this serious disease and enables the potential for an accelerated FDA review timeline The designation is supported ...

Anifrolumab yielded positive outcomes, including remission in 26% of patients, at 6 months across a real-word, multicenter cohort of patients with systemic lupus erythematosus, according to data ...

Lori Sepich smoked for years and sometimes skipped taking her blood pressure medicine. But she never thought she’d have a heart attack.

Inequitable access to oxygen for people with chronic lung diseases is un-CanadianToronto, Ontario--(Newsfile Corp. - March 3, 2026) - Oxygen therapy is a lifeline for people living with chronic lung ...

Questions about the future of the attack on Iran, and other reader perspectives. Also: Drug ads as a resource for patients.

Higher rates of mortality seen among patients with systemic lupus erythematosus, with disparities by sex, race and ethnicity, and region.

Artificial intelligence is emerging as a powerful tool for improving the diagnosis, phenotyping, and treatment of inflammatory skin diseases such as alopecia.

Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, today announced that management will participate in the following investor conferences: ...